802 publications
| Name | Date | Type | Actions |
|---|---|---|---|
In 2023 Vetoquinol celebrates its 90th anniversary. The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
31/01/2023 | Public releases | |
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
18/01/2023 | Public releases | |
CALENDAR 2023 Stock exchange market – non authorized periods The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities. |
13/01/2023 | Financial Documents | |
2023 calendar of financial communication Vetoquinol published its calendar of financial communication for 2023. |
10/01/2023 | Agenda | |
Monthly information regarding the total number of voting rights - december 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/01/2023 | Voting rights | |
Buyback programs - december 2022 Monthly communication regarding buyback programs |
04/01/2023 | Description of buyback programs | |
Monthly information regarding the total number of voting rights ans shares making of the share capital - november As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
08/12/2022 | Voting rights | |
Buyback programs - november 2022 Monthly communication regarding buyback programs |
08/12/2022 | Description of buyback programs | |
Monthly communication regarding buyback programs - october 2022 |
10/11/2022 | Voting rights | |
Buyback programs - october 2022 Monthly communication regarding buyback programs |
10/11/2022 | Description of buyback programs |